Supernus Pharmaceuticals | SUPN - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 2.94M 2026-03
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 58.95M 2.24M 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 422.07M 53.78M 2026-03
Cara Therapeutics USD 9.38M 2.01K 2026-03
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Eisai JPY 282.46M 345K 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Novo Nordisk DKK 4.43B 13.25M 2026-06
Pacira USD 39.82M 512K 2026-06
Perrigo USD 138.1M 500K 2026-03
Pfizer USD 5.7B 0 2026-06
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
United Therapeutics USD 42.68M 521K 2026-06
Xeris Pharmaceuticals USD 172.56M 6.34M 2026-03